Rheumatoid arthritis (RA) has long been established to have pulmonary manifestations such as interstitial lung disease (ILD), and several research groups are pursuing this respiratory burden of RA at #ACR20.
Dr. John Cush RheumNow
5 years 10 months ago
Avacopan - C5a Receptor Inhibitor - in ANCA-Associated Vasculitis: Dr. Arthur Kavanaugh #ACR20
https://t.co/kJxdgoL5EI https://t.co/uYUwUr53lL
Dr. John Cush RheumNow
5 years 10 months ago
Watch our video titled "Outcomes for Rheumatic Disease Patients with COVID-19" with Dr Kathryn Dao ( @KDAO2011) #ACR20
https://t.co/771RLB0pqA https://t.co/glr98MQHac
Dr. John Cush RheumNow
5 years 10 months ago
Reactive Arthritis - Chronic v. Acute: Dr. Janet Pope (@Janetbirdope) #ACR20 https://t.co/BNFqgrckLq https://t.co/oEPe8hfG37
Dr. John Cush RheumNow
5 years 10 months ago
Healthcare Disparities: Dr. Eric Dein ( @ejdein1) discusses abstracts #0049 and #0045 presented at #ACR20.
https://t.co/hUbVnGO4Ji https://t.co/jHMnKHY3UH
Dr. John Cush RheumNow
5 years 10 months ago
Telemedicine Studies: A Trainee’s Perspective by Mrinalini Dey ( @DrMiniDey ) COVID-19 has shifted face to face to consultations--an important change in rheumatology practice. #ACR20 https://t.co/IzvyeFC8w8 https://t.co/SIQxfuUuEk
Dr. John Cush RheumNow
5 years 10 months ago
Check out our article titled Undifferentiated Autoinflammatory Syndrome Called VEXAS by @RheumNow. We recap Saturday's session on autoinflammatory syndromes featuring Dr. Dan Kastner. #ACR20 https://t.co/4jELWl5f88 https://t.co/l95F9C0V31
Dr. John Cush RheumNow
5 years 10 months ago
Moderna mRNA-1273 vaccine, developed for COVID-19, yielded 94.5% efficacy in early results of the phase 3 COVE trial. 90 who were COVID-19 pos were in a placebo group and that 5 patients were in the mRNA-1273 vaccine group. https://t.co/9245wj3kph
Dr. John Cush RheumNow
5 years 10 months ago
Dr. Mrinalini Dey ( @DrMiniDey) Interviews Dr. Marwan Bukhari. He talks about the significant increase in submissions to Rheumatology - especially COVID-19 related, the machine learning and other studies. #ACR20
https://t.co/kVE6Fy718f https://t.co/8XDhBl8knS
Dr. John Cush RheumNow
5 years 10 months ago
Read our article titled: Best Imaging Techniques for non ANCA Vasculitis by Dr. Alexa Meara ( @lexmeara) as discussed at #ACR20 https://t.co/CyfC8bdq42 https://t.co/HrMGvqcNC4
Dr. John Cush RheumNow
5 years 10 months ago
Treat to Target for PsA Patients Abstracts: Dr. Rachel Tate ( @uptoTate)
https://t.co/uYBMNiyUqY https://t.co/sUTN187ilp
Dr. John Cush RheumNow
5 years 10 months ago
Read Dr. Robert Chao's (@doctorRBC) review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment from #ACR20. https://t.co/BeG1DMssoU https://t.co/ywbvH7qmHY
Dr. John Cush RheumNow
5 years 10 months ago
Dr. Janet Pope ( @Janetbirdope) interviews A&R Editor Dr. Daniel Solomon about his role as editor, COVID-19 related submissions, and overall journal submissions. #ACR20
https://t.co/eviV8bsbTZ https://t.co/tNWN0q8B64
There is much controversy regarding vaccine safety and efficacy in the United States. Prior to COVID19, there were populations who lacked confidence in vaccination for any number of reasons. Dr. Grace Lee presented a great overview of the vaccination recommendation to adoption framework that is worth review in light of the ongoing COVID-19 vaccine trials.
